Patent: 7,229,618
✉ Email this page to a colleague
Summary for Patent: 7,229,618
Title: | Crystals and structure of Synagis Fab |
Abstract: | The present invention provides crystalline forms and three-dimensional atomic structure coordinates of Synagis Fab. The present invention further provides methods of using such three-dimensional atomic structure coordinates for designing and identifying Synagis binding agents. The present invention also provides machine readable media embedded with the three-dimensional atomic structure coordinates of Synagis Fab and methods of using them. |
Inventor(s): | Johnson; Leslie S. (Darnestown, MD), Braden; Bradford (Baltimore, MD) |
Assignee: | Medimmune, Inc. (Gaithersburg, MD) Bowie State University (Bowie, MD) |
Application Number: | 11/207,142 |
Patent Claims: | see list of patent claims |
Details for Patent 7,229,618
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | For Injection | 103770 | 06/19/1998 | ⤷ Try a Trial | 2021-05-01 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | Injection | 103770 | 07/23/2004 | ⤷ Try a Trial | 2021-05-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |